Recent analysts Ratings: Kimco Realty Corporation(NYSE:KIM): Supernus Pharmaceuticals, Inc.(NASDAQ:SUPN)

0
6

Kimco Realty Corporation (KIM) will report its next earnings on May 02 BMO. The company reported the earnings of $0.24/Share in the last quarter where the estimated EPS by analysts was $0.16/share. The difference between the expected and actual EPS was $0.08/share, which represents an Earnings surprise of 50%.

Many analysts are providing their Estimated Earnings analysis for Kimco Realty Corporation and for the current quarter 1 analysts have projected that the stock could give an Average Earnings estimate of $0.2/share. These analysts have also projected a Low Estimate of $0.2/share and a High Estimate of $0.2/share.

In case of Revenue Estimates, 3 analysts have provided their consensus Average Revenue Estimates for Kimco Realty Corporation as 283.42 Million. According to these analysts, the Low Revenue Estimate for Kimco Realty Corporation is 276.48 Million and the High Revenue Estimate is 289.04 Million. The company had Year Ago Sales of 222.65 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for KIM to be -2.7%. They are projecting Next Quarter growth of 2.78%. For the next 5 years, Kimco Realty Corporation is expecting Growth of 3.65% per annum, whereas in the past 5 years the growth was 0.69% per annum.

Some buy side analysts are also providing their Analysis on Kimco Realty Corporation, where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 2 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Kimco Realty Corporation might touch $20 high while the Average Price Target and Low price Target is $17.79 and $14.5 respectively.

Kimco Realty Corporation closed its last trading session at $18.09 with the gain of 0.66%. The Market Capitalization of the company stands at 7.55 Billion. The Company has 52-week high of $18.64 and 52-week low of $13.86. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 2.64% where SMA50 and SMA200 are 1.81% and 8.79% respectively. The Company Touched its 52-Week High on 03/28/19 and 52-Week Low on 05/17/18.

The Relative Volume of the company is 0.77 and Average Volume (3 months) is 3.38 million. The company’s P/E (price to earnings) ratio is 37.24 and Forward P/E ratio of 25.9.

The company shows its Return on Assets (ROA) value of 0%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is 3.3%.

While looking at the Stock’s Performance, Kimco Realty Corporation currently shows a Weekly Performance of 1.39%, where Monthly Performance is -0.16%, Quarterly performance is 2.71%, 6 Months performance is 11.79% and yearly performance percentage is 26.2%. Year to Date performance value (YTD perf) value is 24.3%. The Stock currently has a Weekly Volatility of 1.59% and Monthly Volatility of 2.31%.

Supernus Pharmaceuticals, Inc. (SUPN) will report its next earnings on May 07 AMC. The company reported the earnings of $0.34/Share in the last quarter where the estimated EPS by analysts was $0.47/share. The difference between the expected and actual EPS was $-0.13/share, which represents an Earnings surprise of -27.7%.

Many analysts are providing their Estimated Earnings analysis for Supernus Pharmaceuticals, Inc. and for the current quarter 8 analysts have projected that the stock could give an Average Earnings estimate of $0.57/share. These analysts have also projected a Low Estimate of $0.51/share and a High Estimate of $0.62/share.

In case of Revenue Estimates, 8 analysts have provided their consensus Average Revenue Estimates for Supernus Pharmaceuticals, Inc. as 110.39 Million. According to these analysts, the Low Revenue Estimate for Supernus Pharmaceuticals, Inc. is 107.1 Million and the High Revenue Estimate is 115.39 Million. The company had Year Ago Sales of 99.54 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for SUPN to be -1.8%. They are projecting Next Quarter growth of 21.15%. For the next 5 years, Supernus Pharmaceuticals, Inc. is expecting Growth of 16.91% per annum, whereas in the past 5 years the growth was 9.27% per annum.

Some buy side analysts are also providing their Analysis on Supernus Pharmaceuticals, Inc., where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Supernus Pharmaceuticals, Inc. might touch $80 high while the Average Price Target and Low price Target is $57.88 and $34 respectively.

Supernus Pharmaceuticals, Inc. closed its last trading session at $33.38 with the gain of 0%. The Market Capitalization of the company stands at 1.75 Billion. The Company has 52-week high of $61.25 and 52-week low of $30.05. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -8.83% where SMA50 and SMA200 are -9.92% and -19.46% respectively. The Company Touched its 52-Week High on 06/29/18 and 52-Week Low on 12/24/18.

The Relative Volume of the company is 0.92 and Average Volume (3 months) is 640.03 million. The company’s P/E (price to earnings) ratio is 17.55 and Forward P/E ratio of 12.11.

The company shows its Return on Assets (ROA) value of 11%. The Return on Equity (ROE) value stands at 24.4%. While it’s Return on Investment (ROI) value is 14.7%.

While looking at the Stock’s Performance, Supernus Pharmaceuticals, Inc. currently shows a Weekly Performance of -9.69%, where Monthly Performance is -11.6%, Quarterly performance is -12.71%, 6 Months performance is -26.73% and yearly performance percentage is -41.49%. Year to Date performance value (YTD perf) value is 0.48%. The Stock currently has a Weekly Volatility of 9.09% and Monthly Volatility of 5.36%.

SHARE